Stock GLMD GALMED PHARMACEUTICALS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Galmed Pharmaceuticals Ltd.

Equities

GLMD

IL0011313900

Market Closed - Nasdaq
Other stock markets
 15:58:16 2024-05-22 EDT 		5-day change 1st Jan Change
0.3975 USD +2.05% Intraday chart for Galmed Pharmaceuticals Ltd. +3.54% -12.64%
04-04 Galmed Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-15 Galmed Pharmaceuticals Ltd. Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of Nash and Liver Fibrosis CI
e6a96a2b0c2a.i1W9BBg4m0AGei1bd4_VDkieluIdBwKKWniFszuSnms._xDobXVW_BQxFGwqAsy7UX7r7IVZcFPrajDD2GroxwDCBY9mdW_5IWEKFQ~bb925be91eae4380ae8f7230355eeb2c
  1. Stock Market
  2. Equities
  3. GLMD Stock
  4. Charts Galmed Pharmaceuticals Ltd.
  5. News Chart